ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619031 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619031; 2) Community: the network communities that were significantly associated with the response to NSC 619031; 3) Molecule: the relationships between components within communities and NSC 619031; 4) MDR: the compounds that were significantly associated with the NSC 619031.

NSC Compound Enrichment Correlation
NSC 357704 Cyanomorpholinodoxorubicin 0.0355196177493895 0.58427634
NSC 606172 Camptothecin Derivative 0.0355196177493895 0.70428903
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0355196177493897 0.021333638
NSC 666388 Null 0.0355196177493897 0.23876761
NSC 676498 TP4EK-K6 0.0355196177493897 -0.098275641
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.03551961774939 0.27686493
NSC 683608 Null 0.03551961774939 0.059919979
NSC 686940 Null 0.03551961774939 0.044837401
NSC 707484 Null 0.03551961774939 -0.058663973
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 0.03551961774939 0.63202069
Total:40  Current:28    [First] [Prev] [Next] [Last]